‘Double-drugs’— A new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker
- 1 June 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (11) , 1227-1231
- https://doi.org/10.1016/s0960-894x(00)00202-x
Abstract
No abstract availableKeywords
Funding Information
- Japan Health Sciences Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 19 references indexed in Scilit:
- Structure−Activity Relationship of Small-Sized HIV Protease Inhibitors Containing AllophenylnorstatineJournal of Medicinal Chemistry, 1999
- Recent advances in the molecular biology of nucleoside transporters of mammalian cellsBiochemistry and Cell Biology, 1998
- The exercise health connectionPublic Health, 1998
- Meeting ReportsJapanese Journal of Human Geography, 1998
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viabilityTalanta, 1997
- ReviewBiological Chemistry Hoppe-Seyler, 1996
- Synthesis and anti-human immunodeficiency virus type 1 activities of new peptido-nucleoside analoguesEuropean Journal of Medicinal Chemistry, 1995
- Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV InfectionsJournal of Medicinal Chemistry, 1995
- SIDE REACTIONS IN PEPTIDE SYNTHESISInternational Journal of Peptide and Protein Research, 1978